New Approaches to Neuroblastoma Therapy (NANT)

Investigator: Katherine K. Matthay, MD
Sponsor: Children's Hospital of Los Angeles

Location(s): United States


The NANT Consortium is comprised of a wide geographic group of institutions throughout North America, committed to working together on clinical trials of novel approaches to treating high-risk neuroblastoma. The NANT consortium is led by pediatric oncologist Dr. Katherine K. Matthay (UCSF) and the NANT Operations Center operates under the direction of Dr. Judith Villablanca (CHLA), NANT Medical Director, and Dr. Araz Marachelian (CHLA), NANT Assistant Medical Director.